They determined that enzyme is missing from all kidney tumor tissue analyzed.

Additionally it is licensed in a number of other countries including Turkey, Switzerland, Croatia and Tunisia. The vaccine was approved for use in america by the US Drug and Food Administration on September 15, 2009. About Novartis Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis gives a diversified portfolio to greatest meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health items. Novartis is the only firm with leading positions in each of these certain areas.5 billion and net income of USD 8.2 billion.